Table 1.
Parameters | Values | Ref. | |
---|---|---|---|
Physicochemical Properties | |||
Molecular Weight (g/mol) | 284.74 | [40] | |
LogPo:w | 2.82 | [35] | |
pKa | 3.4 | [41] | |
Absorption | |||
Model | |||
Peff,man (cm/s) | 12.434 × 10−4 a,b | [35] | |
PSA (Ao) | 32.67 | [39] | |
HBD | 0 | [39] | |
Distribution | |||
Model Prediction Method | The Rodger and Rowland Method + Ion Membrane Permeability | ||
B/P ratio | 0.58 | [41] | |
fu | 0.03 | [3,42] | |
Vss (L/kg) | 0.66 a,c | [35,43] | |
For Intranasal Administration | |||
Lung fa | 0.7 d | ||
Lung ka | 1.6 d,e | ||
Elimination | |||
fumic | 0.59 a | ||
N-demethylation | Vmax (pmol/min/pmol) | Km (μM) | |
CYP2B6 | 3.6 | 113 | [44] |
CYP2C19 | 2.3 | 32 | |
CYP3A4 | 14.8 | 1828 | |
CYP3A5 | 1.8 | 293 | |
3-hydroxylation | |||
CYP2B6 | 0.1 | 150 | [44] |
CYP2C19 | 20.2 | 846 | |
CYP3A4 | 151.3 | 2235 | |
CYP3A5 | 48.4 | 316 |
a Value predicted by Simcyp, b reported value, c the reported value range was 0.59−1 L/kg, d adjusted by manual optimization, e adjusted to 3.2 while simulating supersaturated solution, blood-to-plasma ratio (B:P), fraction unbound (fu), Michaelis–Menten constant (Km), maximum rate of metabolic formation (Vmax), the volume of distribution at steady-state (Vss), human jejunum permeability (Peff), polar surface area (PSA), hydrogen bonding donor (HBD), acid dissociation constant (pKa), octanol–water partition coefficient (LogPo:w), fraction absorbed (fa), and absorption rate constant (ka).